TP53 and non-small cell lung carcinoma: For instance, prior studies reported that TP53 missense mutations, nondisruptive mutations, and exon 8 mutations acted as negative‐independent prognostic indicators in EGFR‐mutated NSCLC patients.13, 14, 15